Elios Therapeutics
PrivateLast Round
Seed
Sep 10, 2015
Total Funding Raised
$2.39M
Company Overview
Elios Therapeutics operates in Healthcare & Life Sciences and is based in Austin, Texas. Its latest recorded funding round was a Seed round in September 2015.
Elios Therapeutics is a biopharmaceutical company that develops personalized therapeutic cancer vaccines for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elios Therapeutics Comparables
Compare Elios Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AiVita Biomedical | 81% | |
| Northwest Biotherapeutics Inc | 73% | |
| Moderna, Inc. | 73% |
For institutional investors. Book with your work email.
Elios Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 24, 2026
Grew 150% QoQ, from 2 to 5 employees.
For institutional investors. Book with your work email.
Elios Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Elios Therapeutics's valuation, stock price, and market status.
Is Elios Therapeutics a public or private company?
Elios Therapeutics is a private company.
What is the current stock price of Elios Therapeutics?
Elios Therapeutics is a private company, so its shares have no public market price. Caplight tracks Elios Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elios Therapeutics worth (valuation)?
Valuation information for Elios Therapeutics is not publicly available.
Can I buy Elios Therapeutics stock?
Elios Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elios Therapeutics's last funding round?
Elios Therapeutics's most recent funding round was Seed on September 10, 2015.
Who are the main investors in Elios Therapeutics?
Investor information for Elios Therapeutics is not publicly disclosed.
Will Elios Therapeutics IPO soon?
No public IPO plans have been announced for Elios Therapeutics.
How can I track Elios Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Elios Therapeutics's shares on secondary markets.